Drug or drug abuse testing agent are a type of diagnostic tool used to detect the presence of drugs or drug components in an individual's body fluids. These tests typically use samples such as urine, saliva, blood, or hair to determine whether an individual has used or abused drugs by detecting specific drug metabolites or the drug itself in the sample. Such tests are widely used in medical, judicial, employment screening and rehabilitation settings.
The global Drug or Substance Abuse Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
Publisher' newest research report, the 鈥淒rug or Substance Abuse Testing Industry Forecast鈥� looks at past sales and reviews total world Drug or Substance Abuse Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug or Substance Abuse Testing sales for 2024 through 2030. With Drug or Substance Abuse Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug or Substance Abuse Testing industry.
This Insight Report provides a comprehensive analysis of the global Drug or Substance Abuse Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug or Substance Abuse Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug or Substance Abuse Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug or Substance Abuse Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug or Substance Abuse Testing.
United States market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Drug or Substance Abuse Testing players cover Boto Bio, Meridian Bioscience, Abbott, BD and 顿谤盲驳别谤, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug or Substance Abuse Testing market by product type, application, key players and key regions and countries.
Segmentation by type
Urine Testing
Saliva Testing
Blood Testing
Hair Testing
Segmentation by application
Hospital
Judicial Body
Employment Screening
Rehabilitation Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boto Bio
Meridian Bioscience
Abbott
BD
顿谤盲驳别谤
LabCorp
Quest Diagnostics
Randox Testing Services
United States Drug Testing Laboratories Inc. (USDTL)
Thermo Fisher Scientific Inc
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Clinical Reference Laboratory Inc.
Cordant Health Solutions
Omega Laboratories Inc.
Psychemedics Corporation
Precision Diagnostics
Siemens Healthineers
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Drug or Substance Abuse Testing 麻豆原创 Size 2019-2030
2.1.2 Drug or Substance Abuse Testing 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug or Substance Abuse Testing Segment by Type
2.2.1 Urine Testing
2.2.2 Saliva Testing
2.2.3 Blood Testing
2.2.4 Hair Testing
2.3 Drug or Substance Abuse Testing 麻豆原创 Size by Type
2.3.1 Drug or Substance Abuse Testing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug or Substance Abuse Testing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Drug or Substance Abuse Testing Segment by Application
2.4.1 Hospital
2.4.2 Judicial Body
2.4.3 Employment Screening
2.4.4 Rehabilitation Center
2.4.5 Others
2.5 Drug or Substance Abuse Testing 麻豆原创 Size by Application
2.5.1 Drug or Substance Abuse Testing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug or Substance Abuse Testing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Drug or Substance Abuse Testing 麻豆原创 Size by Player
3.1 Drug or Substance Abuse Testing 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Drug or Substance Abuse Testing Revenue by Players (2019-2024)
3.1.2 Global Drug or Substance Abuse Testing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drug or Substance Abuse Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug or Substance Abuse Testing by Regions
4.1 Drug or Substance Abuse Testing 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Drug or Substance Abuse Testing 麻豆原创 Size Growth (2019-2024)
4.3 APAC Drug or Substance Abuse Testing 麻豆原创 Size Growth (2019-2024)
4.4 Europe Drug or Substance Abuse Testing 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Drug or Substance Abuse Testing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Drug or Substance Abuse Testing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Drug or Substance Abuse Testing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Drug or Substance Abuse Testing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug or Substance Abuse Testing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Drug or Substance Abuse Testing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Drug or Substance Abuse Testing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug or Substance Abuse Testing by Country (2019-2024)
7.2 Europe Drug or Substance Abuse Testing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Drug or Substance Abuse Testing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug or Substance Abuse Testing by Region (2019-2024)
8.2 Middle East & Africa Drug or Substance Abuse Testing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Drug or Substance Abuse Testing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Drug or Substance Abuse Testing 麻豆原创 Forecast
10.1 Global Drug or Substance Abuse Testing Forecast by Regions (2025-2030)
10.1.1 Global Drug or Substance Abuse Testing Forecast by Regions (2025-2030)
10.1.2 Americas Drug or Substance Abuse Testing Forecast
10.1.3 APAC Drug or Substance Abuse Testing Forecast
10.1.4 Europe Drug or Substance Abuse Testing Forecast
10.1.5 Middle East & Africa Drug or Substance Abuse Testing Forecast
10.2 Americas Drug or Substance Abuse Testing Forecast by Country (2025-2030)
10.2.1 United States Drug or Substance Abuse Testing 麻豆原创 Forecast
10.2.2 Canada Drug or Substance Abuse Testing 麻豆原创 Forecast
10.2.3 Mexico Drug or Substance Abuse Testing 麻豆原创 Forecast
10.2.4 Brazil Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3 APAC Drug or Substance Abuse Testing Forecast by Region (2025-2030)
10.3.1 China Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3.2 Japan Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3.3 Korea Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3.4 Southeast Asia Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3.5 India Drug or Substance Abuse Testing 麻豆原创 Forecast
10.3.6 Australia Drug or Substance Abuse Testing 麻豆原创 Forecast
10.4 Europe Drug or Substance Abuse Testing Forecast by Country (2025-2030)
10.4.1 Germany Drug or Substance Abuse Testing 麻豆原创 Forecast
10.4.2 France Drug or Substance Abuse Testing 麻豆原创 Forecast
10.4.3 UK Drug or Substance Abuse Testing 麻豆原创 Forecast
10.4.4 Italy Drug or Substance Abuse Testing 麻豆原创 Forecast
10.4.5 Russia Drug or Substance Abuse Testing 麻豆原创 Forecast
10.5 Middle East & Africa Drug or Substance Abuse Testing Forecast by Region (2025-2030)
10.5.1 Egypt Drug or Substance Abuse Testing 麻豆原创 Forecast
10.5.2 South Africa Drug or Substance Abuse Testing 麻豆原创 Forecast
10.5.3 Israel Drug or Substance Abuse Testing 麻豆原创 Forecast
10.5.4 Turkey Drug or Substance Abuse Testing 麻豆原创 Forecast
10.5.5 GCC Countries Drug or Substance Abuse Testing 麻豆原创 Forecast
10.6 Global Drug or Substance Abuse Testing Forecast by Type (2025-2030)
10.7 Global Drug or Substance Abuse Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Boto Bio
11.1.1 Boto Bio Company Information
11.1.2 Boto Bio Drug or Substance Abuse Testing Product Offered
11.1.3 Boto Bio Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Boto Bio Main Business Overview
11.1.5 Boto Bio Latest Developments
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Information
11.2.2 Meridian Bioscience Drug or Substance Abuse Testing Product Offered
11.2.3 Meridian Bioscience Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Meridian Bioscience Main Business Overview
11.2.5 Meridian Bioscience Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Drug or Substance Abuse Testing Product Offered
11.3.3 Abbott Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Drug or Substance Abuse Testing Product Offered
11.4.3 BD Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 顿谤盲驳别谤
11.5.1 顿谤盲驳别谤 Company Information
11.5.2 顿谤盲驳别谤 Drug or Substance Abuse Testing Product Offered
11.5.3 顿谤盲驳别谤 Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 顿谤盲驳别谤 Main Business Overview
11.5.5 顿谤盲驳别谤 Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Drug or Substance Abuse Testing Product Offered
11.6.3 LabCorp Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Information
11.7.2 Quest Diagnostics Drug or Substance Abuse Testing Product Offered
11.7.3 Quest Diagnostics Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Quest Diagnostics Main Business Overview
11.7.5 Quest Diagnostics Latest Developments
11.8 Randox Testing Services
11.8.1 Randox Testing Services Company Information
11.8.2 Randox Testing Services Drug or Substance Abuse Testing Product Offered
11.8.3 Randox Testing Services Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Randox Testing Services Main Business Overview
11.8.5 Randox Testing Services Latest Developments
11.9 United States Drug Testing Laboratories Inc. (USDTL)
11.9.1 United States Drug Testing Laboratories Inc. (USDTL) Company Information
11.9.2 United States Drug Testing Laboratories Inc. (USDTL) Drug or Substance Abuse Testing Product Offered
11.9.3 United States Drug Testing Laboratories Inc. (USDTL) Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 United States Drug Testing Laboratories Inc. (USDTL) Main Business Overview
11.9.5 United States Drug Testing Laboratories Inc. (USDTL) Latest Developments
11.10 Thermo Fisher Scientific Inc
11.10.1 Thermo Fisher Scientific Inc Company Information
11.10.2 Thermo Fisher Scientific Inc Drug or Substance Abuse Testing Product Offered
11.10.3 Thermo Fisher Scientific Inc Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Thermo Fisher Scientific Inc Main Business Overview
11.10.5 Thermo Fisher Scientific Inc Latest Developments
11.11 Siemens Healthineers AG
11.11.1 Siemens Healthineers AG Company Information
11.11.2 Siemens Healthineers AG Drug or Substance Abuse Testing Product Offered
11.11.3 Siemens Healthineers AG Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Siemens Healthineers AG Main Business Overview
11.11.5 Siemens Healthineers AG Latest Developments
11.12 F. Hoffmann-La Roche Ltd
11.12.1 F. Hoffmann-La Roche Ltd Company Information
11.12.2 F. Hoffmann-La Roche Ltd Drug or Substance Abuse Testing Product Offered
11.12.3 F. Hoffmann-La Roche Ltd Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.12.5 F. Hoffmann-La Roche Ltd Latest Developments
11.13 Clinical Reference Laboratory Inc.
11.13.1 Clinical Reference Laboratory Inc. Company Information
11.13.2 Clinical Reference Laboratory Inc. Drug or Substance Abuse Testing Product Offered
11.13.3 Clinical Reference Laboratory Inc. Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Clinical Reference Laboratory Inc. Main Business Overview
11.13.5 Clinical Reference Laboratory Inc. Latest Developments
11.14 Cordant Health Solutions
11.14.1 Cordant Health Solutions Company Information
11.14.2 Cordant Health Solutions Drug or Substance Abuse Testing Product Offered
11.14.3 Cordant Health Solutions Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Cordant Health Solutions Main Business Overview
11.14.5 Cordant Health Solutions Latest Developments
11.15 Omega Laboratories Inc.
11.15.1 Omega Laboratories Inc. Company Information
11.15.2 Omega Laboratories Inc. Drug or Substance Abuse Testing Product Offered
11.15.3 Omega Laboratories Inc. Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Omega Laboratories Inc. Main Business Overview
11.15.5 Omega Laboratories Inc. Latest Developments
11.16 Psychemedics Corporation
11.16.1 Psychemedics Corporation Company Information
11.16.2 Psychemedics Corporation Drug or Substance Abuse Testing Product Offered
11.16.3 Psychemedics Corporation Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Psychemedics Corporation Main Business Overview
11.16.5 Psychemedics Corporation Latest Developments
11.17 Precision Diagnostics
11.17.1 Precision Diagnostics Company Information
11.17.2 Precision Diagnostics Drug or Substance Abuse Testing Product Offered
11.17.3 Precision Diagnostics Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Precision Diagnostics Main Business Overview
11.17.5 Precision Diagnostics Latest Developments
11.18 Siemens Healthineers
11.18.1 Siemens Healthineers Company Information
11.18.2 Siemens Healthineers Drug or Substance Abuse Testing Product Offered
11.18.3 Siemens Healthineers Drug or Substance Abuse Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Siemens Healthineers Main Business Overview
11.18.5 Siemens Healthineers Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
